Overview

Food Effect Study of ModraDoc006 in Combination With Ritonavir

Status:
Completed
Trial end date:
2018-04-04
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of food on the pharmacokinetics of ModraDoc006 in combination with ritonavir, in an open-label, cross-over design. Patients will be randomized into two treatment groups receiving ModraDoc006/r week 1 under fasting and week 2 under fed condition, or vice versa.
Phase:
Phase 1
Details
Lead Sponsor:
Modra Pharmaceuticals
Collaborator:
The Netherlands Cancer Institute
Treatments:
Docetaxel
Ritonavir